First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - INVEST PHARMACO LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: INVEST PHARMACO LTD, Holly Tree Barn, Hambleden, Henley-On-Thames, Oxfordshire, RG9 6NB. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 31 May 2018. The company was incorporated on 24 May 2013.

The accounts next due date is 29 February 2020. There are no mortgages.

The above was based on public record information as at 6 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08543933
Date Incorporated: 24 May 2013
Date Latest Accounts: 31 May 2018
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 08543933
Annual Return: 24 May 2016
Registered Office: Holly Tree Barn, Hambleden, Henley-On-Thames, Oxfordshire, RG9 6NB
SIC Code and Operations: 64991
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

INVEST PHARMACO LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 16 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
11733265 INVEST PLATFORM LIMITED Active - Proposal to Strike off
13248512 INVEST PLAZ LTD Active - Proposal to Strike off
11609873 INVEST PLYN LTD Active - Proposal to Strike off
12509062 INVEST PRO SOLUTIONS LTD Active - Proposal to Strike off
12986800 INVEST PROFESSIONAL LTD Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd